Azenta, Inc. (AZTA) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Azenta, Inc. · Health Care · ref. ETF XLV · 50 calls · price $33.61
What the company does: Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples.
📈 Azenta, Inc. (AZTA) stock price
$33.61+12.3% over range
Aug 28, 25low $16.02 · high $41.01Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 2 analysts
📊 JPI status : Azenta, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 AZTA price target & analyst consensus — price $33.61
The price target · all analysts combined (2 targets)
Highest target · 1 firm of 2$37+10.1%
Median target · of 2 targets$36+7.1%
Lowest target · 1 firm of 2$35+4.1%
Current price$33.61
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 2 ratings (last 6 months)
Strong Buy00%
Buy2100%
Hold00%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 AZTA price target all
All 50 calls, one by one, with our verdict on each firm.
→ See all 50 targets, analyst by analyst💡 The best analysts on AZTA most reliable
Their real reliability on AZTA, firm by firm: who was right, who was wrong.
→ See their reliability on AZTAAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Azenta, Inc.? The JPI assistant answers using our backtest data.
🏛️ Azenta, Inc. insider buying: who's buying and how much › open the full page
1 insider bought1 buys / 6 mo $164k
🔎 Detailed analyses
🏛️ Which US Congress members hold Azenta, Inc. (AZTA)?
2 Congress members have disclosed AZTA buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Gilbert Cisneros 3× · 48%Josh Gottheimer 1× · 56%
✅ Historical analyst reliability on AZTA
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Keybanc ↗ | 50% | -15.9% | 2 |
| B. Riley Securities ↗ | 33% | -4.5% | 3 |
| Needham ↗ | 19% | -20.2% | 21 |
| Stephens & Co. ↗ | 0% | -31.9% | 2 |
📊 What $1,000 invested in Azenta, Inc. would be worth › open the full page
In short — $1,000 invested in Azenta, Inc. 10 years ago would be worth $2,382 today, i.e. +9%/yr on average. Best year: 2020 (+62%), worst: 2022 (-44%). Price performance, excluding dividends.
If I'd invested $1,000 in Azenta, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $509 | -49% |
| 3 years ago | $437 | -56% |
| 5 years ago | $375 | -63% |
Return by year (Azenta, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -24% | $765 (-24%) |
| 2025 | -33% | $509 (-49%) |
| 2024 | -23% | $391 (-61%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Azenta, Inc.
Loading news…
📋 All analyst calls on AZTA
Filtered on — · ✕ show all
Evercore ISI Group ↗
Aug 6, 26
▲ Outperform · 🎯$35
Price at call : $32.04 — upside +9%
Today : $33.61 — upside +4%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Buy · 🎯$37
Price at call : $30.74 — upside +20%
Today : $33.61 — upside +10%
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Aug 5, 27
matures : Aug 5, 27
▲ Buy · 🎯$33
Price at call : $18.57 — upside +78%
Today : $33.61 — upside -2%
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$35
Price at call : $21.71 — upside +61%
Today : $33.61 — upside +4%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Buy · 🎯$44
Price at call : $22.03 — upside +100%
Today : $33.61 — upside +31%
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Mar 17, 27
matures : Mar 17, 27
Evercore ISI Group ↗
Feb 5, 26
▲ Outperform · 🎯$45
Price at call : $27.85 — upside +62%
Today : $33.61 — upside +34%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Feb 5, 27
matures : Feb 5, 27
▲ Buy · 🎯$40
Price at call : $27.85 — upside +44%
Today : $33.61 — upside +19%
🎯 on AZTA : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
▲ Buy · 🎯$44
Price at call : $27.85 — upside +58%
Today : $33.61 — upside +31%
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Feb 4, 27
matures : Feb 4, 27
See the other 42 calls, newest to oldest
■ Hold neutral · not a buy · 🎯$39
Price at call : $37.92 — gap to target +3%
Today : $33.61 — gap to target +16%
🎯 on AZTA : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
Evercore ISI Group ↗
Jan 5, 26
▲ Outperform · 🎯$50
Price at call : $36.98 — upside +35%
Today : $33.61 — upside +49%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
▲ Buy · 🎯$44
Price at call : $34.43 — upside +28%
Today : $33.61 — upside +31%
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Dec 19, 26
matures : Dec 19, 26
Raymond James ↗
Nov 25, 25
▲ Outperform · 🎯$45
Price at call : $36.27 — upside +24%
Today : $33.61 — upside +34%
🎯 on AZTA : 100% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
▲ Buy · 🎯$42
Price at call : $34.89 — upside +20%
Today : $33.61 — upside +25%
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Nov 21, 26
matures : Nov 21, 26
▲ Buy · 🎯$38
Price at call : $29.9 — upside +27%
Today : $33.61 — upside +13%
🎯 on AZTA : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Oct 30, 26
matures : Oct 30, 26
Raymond James ↗
Aug 6, 25
▲ Outperform · 🎯$35
Price at call : $28.4 — upside +23%
Today : $33.61 — upside +4%
Expected +23% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 100% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
+8.2%
stock +8% · XLV +26%
matured Aug 6, 26
Evercore ISI Group ↗
Aug 5, 25
■ In-Line neutral · not a buy · 🎯$33
Price at call : $28.4 — gap to target +16%
Today : $33.61 — gap to target -2%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Aug 5, 26
matures : Aug 5, 26
Evercore ISI Group ↗
Jul 8, 25
■ In-Line neutral · not a buy · 🎯$35
Price at call : $33.51 — gap to target +4%
Today : $33.61 — gap to target +4%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Jul 8, 26
matures : Jul 8, 26
▲ Buy · 🎯$40
Price at call : $27.71 — upside +44%
Today : $33.61 — upside +19%
Expected +44% · Actual -31% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-30.6%
stock -31% · XLV +7%
matured May 7, 26
Evercore ISI Group ↗
Feb 6, 25
■ In-Line neutral · not a buy · 🎯$52
Price at call : $52.32 — gap to target -1%
Today : $33.61 — gap to target +55%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Feb 6, 26
matures : Feb 6, 26
▲ Buy · 🎯$59
Price at call : $54.04 — upside +9%
Today : $33.61 — upside +76%
Expected +9% · Actual -47% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-46.9%
stock -47% · XLV +7%
matured Feb 6, 26
Stephens & Co. ↗
Jan 2, 25
▲ Overweight · 🎯$60
Price at call : $50.04 — upside +20%
Today : $33.61 — upside +79%
Expected +20% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-33.3%
stock -33% · XLV +13%
matured Jan 2, 26
Stephens & Co. ↗
Dec 18, 24
▲ Overweight · 🎯$60
Price at call : $49.5 — upside +21%
Today : $33.61 — upside +79%
Expected +21% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
-30.4%
stock -30% · XLV +14%
matured Dec 18, 25
▲ Buy · 🎯$55
Price at call : $44.51 — upside +24%
Today : $33.61 — upside +64%
Expected +24% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-32.9%
stock -33% · XLV +4%
matured Nov 13, 25
Evercore ISI Group ↗
Oct 1, 24
■ In-Line neutral · not a buy · 🎯$50
Price at call : $47.72 — gap to target +5%
Today : $33.61 — gap to target +49%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Oct 1, 25
matures : Oct 1, 25
▲ Buy · 🎯$69
Price at call : $53.13 — upside +30%
Today : $33.61 — upside +105%
Expected +30% · Actual -45% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-45.2%
stock -45% · XLV -12%
matured Aug 7, 25
Evercore ISI Group ↗
Jul 2, 24
■ In-Line neutral · not a buy · 🎯$53
Price at call : $51.95 — gap to target +2%
Today : $33.61 — gap to target +58%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Jul 2, 25
matures : Jul 2, 25
▲ Buy · 🎯$69
Price at call : $52.51 — upside +31%
Today : $33.61 — upside +105%
Expected +31% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-49.0%
stock -49% · XLV -7%
matured May 9, 25
▲ Buy · 🎯$75
Price at call : $57.81 — upside +30%
Today : $33.61 — upside +123%
Expected +30% · Actual -49% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-48.8%
stock -49% · XLV -3%
matured Apr 9, 25
Evercore ISI Group ↗
Apr 4, 24
■ In-Line neutral · not a buy · 🎯$60
Price at call : $57.48 — gap to target +4%
Today : $33.61 — gap to target +79%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Apr 4, 25
matures : Apr 4, 25
■ Hold neutral · not a buy · 🎯$64
Price at call : $58.17 — gap to target +10%
Today : $33.61 — gap to target +90%
🎯 on AZTA : no call matured yet · 📊 on Health : 50% · +9.9% (136 calls)
in progress (365j)
matures : Apr 4, 25
matures : Apr 4, 25
▲ Buy · 🎯$75
Price at call : $60.28 — upside +24%
Today : $33.61 — upside +123%
Expected +24% · Actual -43% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-42.6%
stock -43% · XLV -2%
matured Mar 28, 25
▲ Buy · 🎯$75
Price at call : $59.51 — upside +26%
Today : $33.61 — upside +123%
Expected +26% · Actual -37% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-37.0%
stock -37% · XLV +1%
matured Mar 14, 25
▲ Buy · 🎯$75
Price at call : $67.14 — upside +12%
Today : $33.61 — upside +123%
Expected +12% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-34.9%
stock -35% · XLV +2%
matured Mar 7, 25
Stephens & Co. ↗
Feb 8, 24
■ Equal-Weight neutral · not a buy · 🎯$70
Price at call : $65.13 — gap to target +7%
Today : $33.61 — gap to target +108%
🎯 on AZTA : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Feb 7, 25
matures : Feb 7, 25
▲ Buy · 🎯$75
Price at call : $64.04 — upside +17%
Today : $33.61 — upside +123%
Expected +17% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-18.3%
stock -18% · XLV +2%
matured Feb 7, 25
B. Riley Securities ↗
Feb 1, 24
▲ Buy · 🎯$79
Price at call : $66.1 — upside +20%
Today : $33.61 — upside +135%
Expected +20% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 50% (2 calls matureds) · 📊 on Health : 48.6% · +36.7% (35 calls)
-21.2%
stock -21% · XLV +4%
matured Jan 31, 25
▲ Buy · 🎯$76
Price at call : $67.41 — upside +13%
Today : $33.61 — upside +126%
Expected +13% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-20.2%
stock -20% · XLV +2%
matured Jan 17, 25
Stephens & Co. ↗
Nov 14, 23
■ Equal-Weight neutral · not a buy · 🎯$55
Price at call : $54.45 — gap to target +1%
Today : $33.61 — gap to target +64%
🎯 on AZTA : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Nov 13, 24
matures : Nov 13, 24
▲ Buy · 🎯$68
Price at call : $54.45 — upside +25%
Today : $33.61 — upside +102%
Expected +25% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-18.3%
stock -18% · XLV +15%
matured Nov 13, 24
Stephens & Co. ↗
Aug 9, 23
■ Equal-Weight neutral · not a buy · 🎯$45
Price at call : $55.7 — gap to target -19%
Today : $33.61 — gap to target +34%
🎯 on AZTA : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Aug 8, 24
matures : Aug 8, 24
▲ Buy · 🎯$65
Price at call : $57.76 — upside +13%
Today : $33.61 — upside +93%
Expected +13% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-3.2%
stock -3% · XLV +11%
matured Aug 8, 24
Raymond James ↗
Jul 19, 23
■ Market Perform neutral · not a buy
🎯 on AZTA : 100% (1 call matured) · 📊 on Health : 39.9% · -2.0% (218 calls)
in progress (365j)
matures : Jul 18, 24
matures : Jul 18, 24
▲ Buy · 🎯$55
Price at call : $36.45 — upside +51%
Today : $33.61 — upside +64%
Expected +51% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+44.1%
stock +44% · XLV +8%
matured May 9, 24
■ Sector Weight neutral · not a buy
🎯 on AZTA : no call matured yet · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : May 9, 24
matures : May 9, 24
▲ Buy · 🎯$68
Price at call : $44.04 — upside +54%
Today : $33.61 — upside +102%
Expected +54% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+14.6%
stock +15% · XLV +3%
matured Apr 17, 24
B. Riley Securities ↗
Feb 10, 23
▲ Buy · 🎯$68
Price at call : $44.8 — upside +52%
Today : $33.61 — upside +102%
Expected +52% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on AZTA : 50% (2 calls matureds) · 📊 on Health : 48.6% · +36.7% (35 calls)
+47.2%
stock +47% · XLV +9%
matured Feb 10, 24
Stephens & Co. ↗
Feb 9, 23
■ Equal-Weight neutral · not a buy · 🎯$60
Price at call : $45.94 — gap to target +31%
Today : $33.61 — gap to target +79%
🎯 on AZTA : 0% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Feb 9, 24
matures : Feb 9, 24
▲ Buy · 🎯$68
Price at call : $45.94 — upside +48%
Today : $33.61 — upside +102%
Expected +48% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+41.8%
stock +42% · XLV +10%
matured Feb 9, 24
▲ Buy · 🎯$78
Price at call : $56.22 — upside +39%
Today : $33.61 — upside +132%
Expected +39% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on AZTA : 24% (17 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+13.9%
stock +14% · XLV +9%
matured Feb 8, 24
Evercore ISI Group ↗
Jan 3, 23
■ In-Line neutral · not a buy · 🎯$62
Price at call : $58.94 — gap to target +5%
Today : $33.61 — gap to target +84%
🎯 on AZTA : no call matured yet · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Jan 3, 24
matures : Jan 3, 24
Frequently asked questions
Should I buy Azenta, Inc. stock?
This isn't buy advice. For Azenta, Inc., the analyst consensus is "Buy", with an average price target of $36.00 (+7% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 50% of the time (2 calls tracked on Azenta, Inc.). We show the numbers — you decide.
Is it too late to buy Azenta, Inc.? How high can it go?
The most bullish analyst target on Azenta, Inc. is $37.00 (+10% above today's price); the average is $36.00. That's the upside they see. Check how reliable those analysts have actually been on Azenta, Inc. on our site before trusting it.
Is Azenta, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 4 analysts have a real record on Azenta, Inc., the best hitting 50% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
What has Azenta, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: AZTA performance & returns.
Are insiders buying AZTA stock?
Executives' and large holders' buys and sells, decoded: insider buying on AZTA.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX